A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

Galina A. Gusarova(Columbia University Irving Medical Center), Robert H. Costa(Baylor College of Medicine)

Journal of Clinical Investigation

December 15, 2006

10.1172/jci27527

Cited by 155

Related Papers

Earlier Expression of the Transcription Factor Hfh–11B Diminishes Induction of P21Cip1/Waf1 Levels and Accelerates Mouse Hepatocyte Entry Into S–Phase Following Carbon Tetrachloride Liver Injury

|Hepatology|2001|89

Actin fence therapy with exogenous V12Rac1 protects against acute lung injury

|JCI Insight|2021|10

Actin fence therapy with exogenous V12Rac1 protects against Acute Lung Injury

|bioRxiv (Cold Spring Harbor Laboratory)|2021|0

High CO 2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)

|UNC Libraries|2020|0